{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:22:45Z","timestamp":1794604965910,"version":"4.9.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ahjo.2026.100907","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:24:39Z","timestamp":1790321079000},"page":"100907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Autoimmune disorders and cardiovascular disease: a matched cross-sectional analysis of disease-specific associations in Qatari primary care"],"prefix":"10.1016","volume":"71","author":[{"given":"Aisha","family":"Al-Khinji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhafer","family":"Malouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif","family":"Al-Hor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghalya","family":"Al Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noora","family":"Al-Korbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hissa","family":"Al-Kuwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deema","family":"Al Rewaily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Matwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Haj","family":"Bakri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ghaith","family":"Al-Kuwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ahjo.2026.100907_bb0005","first-page":"2968","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"64","author":"Avi\u00f1a-Zubieta","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.ahjo.2026.100907_bb0010","article-title":"Sex-specific differences in the presentation of cardiovascular disease in systemic lupus erythematosus","volume":"5","author":"Schoenfeld","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100907_bb0015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am. J. Epidemiol."},{"issue":"16","key":"10.1016\/j.ahjo.2026.100907_bb0020","first-page":"2954","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"116","author":"Denny","year":"2010","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.ahjo.2026.100907_bb0025","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100907_bb0030","first-page":"1136","article-title":"The impact of biologic therapies on cardiovascular risk in rheumatoid arthritis: a systematic review and meta-analysis","volume":"69","author":"Low","year":"2017","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100907_bb0035","first-page":"184","article-title":"Comparative cardiovascular risk of methotrexate versus anti-tumor necrosis factor-alpha agents in patients with rheumatoid arthritis","volume":"163","author":"Solomon","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.ahjo.2026.100907_bb0040","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100907_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of c-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ahjo.2026.100907_bb0050","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahjo.2026.100907_bb0055","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/01.CIR.0000120707.98922.E3","article-title":"C-reactive protein modulates risk prediction based on the Framingham score: results from a large cohort study in southern Germany","volume":"109","author":"Koenig","year":"2004","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ahjo.2026.100907_bb0060","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/archinte.165.21.2473","article-title":"C-reactive protein and risk of cardiovascular disease in men and women from the Framingham heart study","volume":"165","author":"Wilson","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ahjo.2026.100907_bb0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/annrheumdis-2014-eular.1742","article-title":"The role of c-reactive protein or erythrocyte sedimentation rate in predicting cardiovascular outcomes in rheumatoid arthritis: analysis of data from US managed care organization","volume":"73","author":"An","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ahjo.2026.100907_bb0070","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/annrheumdis-2014-eular.1833","article-title":"Performance of the Framingham cardiovascular risk prediction model with and without c-reactive protein or erythrocyte sedimentation rate in ra: analysis of us electronic medical records database","volume":"73","author":"Rajagopalan","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ahjo.2026.100907_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006242","article-title":"Levels of c-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis","volume":"4","author":"Graf","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ahjo.2026.100907_bb0080","series-title":"Qatar Foundation Annual Research Conference Proceedings","article-title":"Obesity in the qatari population: an epidemiological perspective","author":"Cheema","year":"2016"},{"key":"10.1016\/j.ahjo.2026.100907_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1035686","article-title":"Core health indicators in countries with high proportion of expatriates: case study of Qatar","volume":"11","author":"Moradi-Lakeh","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ahjo.2026.100907_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jclinepi.2019.02.004","article-title":"A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models","volume":"110","author":"Christodoulou","year":"2019","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ahjo.2026.100907_bb0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jclinepi.2020.03.002","article-title":"Logistic regression was as good as machine learning for predicting major chronic diseases","volume":"122","author":"Nusinovici","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ahjo.2026.100907_bb0100","article-title":"Understanding the epidemiological characteristics of the primary healthcare corporation-based COVID-19 swabbed persons in Qatar, 2020","volume":"2022","author":"Abdulmalik","year":"2022","journal-title":"Q. Med. J."},{"key":"10.1016\/j.ahjo.2026.100907_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304160","article-title":"Health risk factors, status and service utilisation of adults in primary health care settings in Qatar: the Healthsight study protocol","volume":"19","author":"Syed","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ahjo.2026.100907_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s40733-019-0050-4","article-title":"Epidemiology and utilization of primary health care services in Qatar by asthmatic children 5\u201312 years old: secondary data analysis 2016\u20132017","volume":"5","author":"Veettil","year":"2019","journal-title":"Asthma Res. Pract."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100907_bb0115","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jamia\/ocw021","article-title":"Missing clinical and behavioral health data in a large electronic health record (ehr) system","volume":"23","author":"Madden","year":"2016","journal-title":"J. Am. Med. Inform. Assoc."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100907_bb0120","doi-asserted-by":"crossref","DOI":"10.13063\/2327-9214.1035","article-title":"Strategies for handling missing data in electronic health record derived data","volume":"1","author":"Wells","year":"2013","journal-title":"eGEMs (Generating Evidence & Methods to improve patient outcomes)"},{"key":"10.1016\/j.ahjo.2026.100907_bb0125","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100907_bb0130","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.ahjo.2026.100907_bb0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat. Med."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100907_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ahjo.2026.100907_bb0145","first-page":"83","article-title":"Estimation of relative risk from matched pairs of cases and controls","volume":"7","author":"Breslow","year":"1978","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100907_bb0150","first-page":"1","article-title":"Comparison of conditional and unconditional logistic regression for matched case-control studies","volume":"9","author":"Kuo","year":"2018","journal-title":"J. Biom. Biostat."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100907_bb0155","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ije\/22.6.1189","article-title":"What does the odds ratio estimate in a case-control study?","volume":"22","author":"Pearce","year":"1993","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100907_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am. J. Med."},{"issue":"10","key":"10.1016\/j.ahjo.2026.100907_bb0165","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100907_bb0170","first-page":"1","article-title":"Atherosclerotic cardiovascular disease in systemic lupus erythematosus","volume":"15","author":"Schoenfeld","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"issue":"9","key":"10.1016\/j.ahjo.2026.100907_bb0175","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.34504","article-title":"Type i interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis","volume":"64","author":"Thacker","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"Suppl. 1","key":"10.1016\/j.ahjo.2026.100907_bb0180","first-page":"S10","article-title":"Antiphospholipid antibodies and the risk of cardiovascular disease: insights from the systemic lupus erythematosus cardiovascular disease study","volume":"119","author":"Salmon","year":"2007","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100907_bb0185","first-page":"1","article-title":"Biomarkers of premature atherosclerosis in systemic lupus erythematosus","volume":"56","author":"Ardoin","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100907_bb0190","first-page":"608","article-title":"Oxidized low-density lipoprotein\/beta2-glycoprotein i complexes and autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"126","author":"Lopez","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100907_bb0195","first-page":"480","article-title":"Association between changes in disease activity and subsequent changes in inflammatory markers: a longitudinal study","volume":"21","author":"Petri","year":"2012","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.ahjo.2026.100907_bb0200","article-title":"Leptin is associated with presence and severity of coronary atherosclerosis in patients with systemic lupus erythematosus","volume":"9","author":"Chung","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ahjo.2026.100907_bb0205","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.21976","article-title":"Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"McMahon","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100907_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101672","article-title":"Risk of subclinical atherosclerosis in patients with antiphospholipid syndrome and subjects with antiphospholipid antibody positivity: a systematic review and meta-analysis","volume":"48","author":"Karakasis","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"issue":"12","key":"10.1016\/j.ahjo.2026.100907_bb0215","first-page":"1690","article-title":"Cardiovascular morbidity and mortality in rheumatoid arthritis","volume":"59","author":"Avi\u00f1a-Zubieta","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ahjo.2026.100907_bb0220","first-page":"62","article-title":"Rheumatoid arthritis and cardiovascular disease","volume":"198","author":"Crowson","year":"2018","journal-title":"Am. Heart J."},{"issue":"10","key":"10.1016\/j.ahjo.2026.100907_bb0225","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","article-title":"Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies","volume":"48","author":"Meune","year":"2009","journal-title":"Rheumatology"},{"issue":"10354","key":"10.1016\/j.ahjo.2026.100907_bb0230","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ahjo.2026.100907_bb0235","first-page":"1","article-title":"Inflammation is linked to cardiovascular risk in rheumatoid arthritis: a meta-analysis of observational studies","volume":"74","author":"Liao","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"24","key":"10.1016\/j.ahjo.2026.100907_bb0240","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"issue":"9313","key":"10.1016\/j.ahjo.2026.100907_bb0245","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ahjo.2026.100907_bb0250","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100907_bb0255","article-title":"Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis","volume":"11","author":"Crowson","year":"2016","journal-title":"PLoS One"},{"issue":"i637","key":"10.1016\/j.ahjo.2026.100907_bb0260","article-title":"Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study","volume":"352","author":"Lindhardsen","year":"2016","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.ahjo.2026.100907_bb0265","first-page":"868","article-title":"Thyroid hormone and heart failure: from myocardial protection to systemic regulation","volume":"91","author":"Biondi","year":"2002","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.ahjo.2026.100907_bb0270","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100907_bb0275","first-page":"1181","article-title":"Association between thyroid dysfunction and outcomes after acute coronary syndrome","volume":"104","author":"Hyland","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ahjo.2026.100907_bb0280","first-page":"1943","article-title":"Cardiovascular biomarkers and risk of mortality in rheumatoid arthritis","volume":"56","author":"Rana","year":"2017","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.ahjo.2026.100907_bb0285","first-page":"1027","article-title":"Elevated C-reactive protein levels are paradoxically associated with lower disease activity in systemic lupus erythematosus","volume":"19","author":"Rosa","year":"2010","journal-title":"Lupus"},{"issue":"14","key":"10.1016\/j.ahjo.2026.100907_bb0290","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100907_bb0295","first-page":"394","article-title":"Inflammatory markers and cardiovascular risk: new insights from the physicians\u2019 health study","volume":"105","author":"Ridker","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ahjo.2026.100907_bb0300","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"issue":"9709","key":"10.1016\/j.ahjo.2026.100907_bb0305","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.ahjo.2026.100907_bb0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.ahjo.2026.100907_bb0315","first-page":"1162","article-title":"Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation","volume":"48","author":"Choy","year":"2009","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.ahjo.2026.100907_bb0320","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrrheum.2013.91","article-title":"Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm","volume":"9","author":"Robertson","year":"2013","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:01:26Z","timestamp":1794603686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602226001965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":64,"alternative-id":["S2666602226001965"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100907","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune disorders and cardiovascular disease: a matched cross-sectional analysis of disease-specific associations in Qatari primary care","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100907"}}